Following a full submission
AWMSG advice |
|||
| Status: Recommended | |||
Avanafil (Spedra®) is recommended as an option for use within NHS Wales for the treatment of erectile dysfunction in adult men. |
|||
|
|||
Medicine details |
|||
| Medicine name | avanafil (Spedra®) | ||
| Formulation | 50 mg tablet, 100 mg tablet, 200 mg tablet | ||
| Reference number | 1261 | ||
| Indication | Treatment of erectile dysfunction in adult men |
||
| Company | A. Menarini Farmaceutica Internazionale SRL | ||
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders | ||
| Submission type | Full | ||
| Status | Recommended | ||
| Advice number | 1715 | ||
| NMG meeting date | 13/05/2015 | ||
| AWMSG meeting date | 17/06/2015 | ||
| Ratification by Welsh Government | 15/07/2015 | ||
| Date of issue | 16/07/2015 | ||
| Date of last review | 18/06/2018 | ||